论文部分内容阅读
目的 :分析米索前列醇和缩宫素联合应用对产后出血的预防效果。方法 :抽取2014年2月—2015年2月时间段内于本院生产的70例产妇作为研究对象,随机分成各40例的观察组和对照组,观察组患者采用缩宫素和米索前列醇预防产后出血,对照组患者仅选择缩宫素预防产后出血。对比两组患者产后出血的预防效果。结果 :观察组患者产后2h出血量和产后24h出血量为(145.50±15.00)ml和(230.50±20.00)ml,明显少于对照组产后2h出血量和产后24h出血量(220.50±15.00)ml和(320.00±18.00)ml,组间对比有显著性差异,P<0.05,具备统计学意义。观察组不良反应发生率11.43%,对照组不良反应发生率2.86%,组间对比无显著性差异,不具备统计学意义,P>0.05。结论 :联合应用米索前列醇和缩宫素,可有效减少产妇产后出血量,不良反应发生率较低,预防效果极佳。
Objective: To analyze the preventive effect of combination of misoprostol and oxytocin on postpartum hemorrhage. Methods: A total of 70 maternal women in our hospital from February 2014 to February 2015 were randomly divided into the observation group (40 cases) and the control group (40 cases). The observation group was treated with oxytocin and misoprostol Alcohol to prevent postpartum hemorrhage, control group patients only choose oxytocin to prevent postpartum hemorrhage. The prevention of postpartum hemorrhage in both groups was compared. Results: The amount of hemorrhage 2h postpartum and the amount of hemorrhage 24 h postpartum were (145.50 ± 15.00) ml and (230.50 ± 20.00) ml in the observation group, which were significantly lower than those in the control group at 2h postpartum and at 24 h postpartum (220.50 ± 15.00) ml and (320.00 ± 18.00) ml, there was significant difference between groups, P <0.05, with statistical significance. The incidence of adverse reactions in the observation group was 11.43%, and the incidence of adverse reactions in the control group was 2.86%. There was no significant difference between the two groups. There was no statistical significance (P> 0.05). Conclusion: The combination of misoprostol and oxytocin can effectively reduce the amount of postpartum hemorrhage, the incidence of adverse reactions is low, and the preventive effect is excellent.